Tumor Suppression and Promotion by Autophagy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ávalos, Yenniffer ^a,b   Canales, Jimena ^a   Bravo Sagua, Roberto ^a,b   Criollo, Alfredo ^b   Lavandero, Sergio ^b,c   Quest, Andrew F G ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; RAS PROTEIN; TUMOR SUPPRESSOR PROTEIN;

AUTOPHAGY; CANCER CONTROL; CANCER INHIBITION; CELL DEATH; CLINICAL TRIAL (TOPIC); HUMAN; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; NECROSIS; ONCOGENE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROMOTER REGION; REGULATORY MECHANISM; REVIEW; SENESCENCE; TUMOR GROWTH; TUMOR PROMOTION; ANIMAL; BIOLOGICAL MODEL; METABOLISM; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; AUTOPHAGY; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84920892844     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/603980     Document Type: Review

References (132)

1. P. Vineis and C. P. Wild, "Global cancer patterns: causes and prevention, " The Lancet, vol. 383, no. 9916, pp. 549-557, 2014.
2. C. Are, S. Rajaram, M. Are, et al., "A review of global cancer burden: trends, challenges, strategies, and a role for surgeons, " Journal of Surgical Oncology, vol. 107, no. 2, pp. 221-226, 2013.
3. D. Hanahan and R. A. Weinberg, "The hallmarks of cancer, " Cell, vol. 100, no. 1, pp. 57-70, 2000.
4. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation, " Cell, vol. 144, no. 5, pp. 646-674, 2011.
5. D. J. Klionsky, "Autophagy revisited: a conversation with Christian de Duve, " Autophagy, vol. 4, no. 6, pp. 740-743, 2008.
6. M. A. Jardon, K. Rothe, S. Bortnik, et al., "Autophagy: from structure to metabolism to therapeutic regulation, " Autophagy, vol. 9, no. 12, pp. 2180-2182, 2013.
7. M. Hayashi-Nishino, N. Fujita, T. Noda, A. Yamaguchi, T. Yoshimori, and A. Yamamoto, "A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation, " Nature Cell Biology, vol. 11, no. 12, pp. 1433-1437, 2009.
8. M. Hayashi-Nishino, N. Fujita, T. Noda, A. Yamaguchi, T. Yoshimori, and A. Yamamoto, "Electron tomography reveals the endoplasmic reticulum as a membrane source for autophagosome formation, " Autophagy, vol. 6, no. 2, pp. 301-303, 2010.
9. M. Hamasaki, N. Furuta, A. Matsuda, et al., "Autophagosomes form at ER-mitochondria contact sites, " Nature, vol. 495, no. 7441, pp. 389-393, 2013.
10. S. A. Tooze and T. Yoshimori, "The origin of the autophagosomal membrane, " Nature Cell Biology, vol. 12, no. 9, pp. 831-835, 2010.
11. K. R. Parzych and D. J. Klionsky, "An overview of autophagy: morphology, mechanism, and regulation, " Antioxidants and Redox Signaling, vol. 20, no. 3, pp. 460-473, 2014.
12. A. Efeyan, R. Zoncu, and D. M. Sabatini, "Amino acids and mTORC1: fromlysosomes to disease, " Trends inMolecularMedicine, vol. 18, no. 9, pp. 524-533, 2012.
13. G. Kroemer, G. Marino, and B. Levine, "Autophagy and the integrated stress response, " Molecular Cell, vol. 40, no. 2, pp. 280-293, 2010.
14. F. OFarrell, T. E. Rusten, and H. Stenmark, "Phosphoinositide 3-kinases as accelerators and brakes of autophagy, " FEBS Journal, vol. 280, no. 24, pp. 6322-6337, 2013.
15. S. F. Funderburk, Q. J. Wang, and Z. Yue, "The Beclin 1-VPS34 complex-at the crossroads of autophagy and beyond, " Trends in Cell Biology, vol. 20, no. 6, pp. 355-362, 2010.
16. Y. Zhong, Q. J. Wang, X. Li, et al., "Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex, " Nature Cell Biology, vol. 11, no. 4, pp. 468-476, 2009.
17. H. E. J. Polson, J. De Lartigue, D. J. Rigden, et al., "Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation, " Autophagy, vol. 6, no. 4, pp. 506-522, 2010.
18. T. Proikas-Cezanne and H. Robenek, "Freeze-fracture replica immunolabelling reveals human WIPI-1 and WIPI-2 as membrane proteins of autophagosomes, " Journal of Cellular and Molecular Medicine, vol. 15, no. 9, pp. 2007-2010, 2011.
19. D. J. Klionsky and B. A. Schulman, "Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins, " Nature Structural and Molecular Biology, vol. 21, no. 4, pp. 336-345, 2014.
20. H. Nakatogawa, "Two ubiquitin-like conjugation systems that mediatemembrane formation during autophagy, " Essays in Biochemistry, vol. 55, no. 1, pp. 39-50, 2013.
21. E. Tasdemir, L. Galluzzi, M. C. Maiuri, et al., "Methods for assessing autophagy and autophagic cell death, " Methods in Molecular Biology, vol. 445, pp. 29-76, 2008.
22. E.-L. Eskelinen, A. L. Illert, Y. Tanaka, et al., "Role of LAMP-2 in lysosome biogenesis and autophagy, " Molecular Biology of the Cell, vol. 13, no. 9, pp. 3355-3368, 2002.
23. X. Ao, L. Zou, and Y. Wu, "Regulation of autophagy by the Rab GTPase network, " Cell Death and Differentiation, vol. 21, no. 3, pp. 348-358, 2014.
24. A. Nara, N. Mizushima, A. Yamamoto, Y. Kabeya, Y. Ohsumi, and T. Yoshimori, "SKD1 AAA ATPase-dependent endosomal transport is involved in autolysosome formation, " Cell Structure and Function, vol. 27, no. 1, pp. 29-37, 2002.
25. M. Mehrpour, A. Esclatine, I. Beau, and P. Codogno, "Overview of macroautophagy regulation in mammalian cells, " Cell Research, vol. 20, no. 7, pp. 748-762, 2010.
26. R. Zoncu, A. Efeyan, and D. M. Sabatini, "MTOR: from growth signal integration to cancer, diabetes and ageing, " Nature Reviews Molecular Cell Biology, vol. 12, no. 1, pp. 21-35, 2011.
27. P. P. Hsu, S. A. Kang, J. Rameseder, et al., "The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling, " Science, vol. 332, no. 6035, pp. 1317-1322, 2011.
28. A. Efeyan, R. Zoncu, S. Chang, et al., "Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival, " Nature, vol. 493, no. 7434, pp. 679-683, 2013.
29. E. Y. Chan, "MTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex, " Science Signaling, vol. 2, no. 84, article pe51, 2009.
30. N. Hosokawa, T. Hara, T. Kaizuka, et al., "Nutrient-dependent mTORCl association with the ULK1-Atg13-FIP200 complex required for autophagy, " Molecular Biology of the Cell, vol. 20, no. 7, pp. 1981-1991, 2009.
31. L. Shang, S. Chen, F. Du, S. Li, L. Zhao, and X. Wang, "Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 4788-4793, 2011.
32. J. Kim, M. Kundu, B. Viollet, and K.-L. Guan, "AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, " Nature Cell Biology, vol. 13, no. 2, pp. 132-141, 2011.
33. J. W. Lee, S. Park, Y. Takahashi, and H.-G. Wang, "The association of AMPK with ULK1 regulates autophagy, " PLoS ONE, vol. 5, no. 11, Article ID e15394, 2010.
34. D. N. Tripathi, R. Chowdhury, L. J. Trudel, et al., "Reactive nitrogen species regulate autophagy through ATM-AMPKTSC2-mediated suppression of mTORC1, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 32, pp. E2950-E2957, 2013.
35. S. Sarkar, "Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers, " Biochemical Society Transactions, vol. 41, no. 5, pp. 1103-1130, 2013.
36. M. Cully, H. You, A. J. Levine, and T. W. Mak, "Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis, " Nature Reviews Cancer, vol. 6, no. 3, pp. 184-192, 2006.
37. B. Levine, S. Sinha, and G. Kroemer, "Bcl-2 family members: dual regulators of apoptosis and autophagy, " Autophagy, vol. 4, no. 5, pp. 600-606, 2008.
38. R. J. Shaw and L. C. Cantley, "Ras, PI(3)K and mTOR signalling controls tumour cell growth, " Nature, vol. 441, no. 7092, pp. 424-430, 2006.
39. G. Marino, N. Salvador-Montoliu, A. Fueyo, E. Knecht, N. Mizushima, and C. Lopez-Otin, "Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3, " Journal of Biological Chemistry, vol. 282, no. 25, pp. 18573-18583, 2007.
40. Z. Lu, R. Z. Luo, Y. Lu, et al., "The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells, " The Journal of Clinical Investigation, vol. 118, no. 12, pp. 3917-3929, 2008.
41. X. H. Liang, S. Jackson, M. Seaman, et al., "Induction of autophagy and inhibition of tumorigenesis by beclin 1, " Nature, vol. 402, no. 6762, pp. 672-676, 1999.
42. V. Labi, M. Erlacher, S. Kiessling, and A. Villunger, "BH3-only proteins in cell death initiation, malignant disease and anticancer therapy, " Cell Death and Differentiation, vol. 13, no. 8, pp. 1325-1338, 2006.
43. E. Lomonosova and G. Chinnadurai, "BH3-only proteins in apoptosis and beyond: an overview, " Oncogene, vol. 27, no. 1, pp. S2-S19, 2008.
44. M. C. Maiuri, A. Criollo, E. Tasdemir, et al., "BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-XL, " Autophagy, vol. 3, no. 4, pp. 374-376, 2007.
45. Y. Takahashi, D. Coppola, N. Matsushita, et al., "Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis, " Nature Cell Biology, vol. 9, no. 10, pp. 1142-1151, 2007.
46. B. Harrison, M. Kraus, L. Burch, et al., "DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing, " The Journal of Biological Chemistry, vol. 283, no. 15, pp. 9999-10014, 2008.
47. J. Liang, S. H. Shao, Z.-X. Xu, et al., "The energy sensing LKB1-AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis, " Nature Cell Biology, vol. 9, no. 2, pp. 218-224, 2007.
48. H. Ji, M. R. Ramsey, D. N. Hayes, et al., "LKB1 modulates lung cancer differentiation and metastasis, " Nature, vol. 448, no. 7155, pp. 807-810, 2007.
49. A. L. Edinger, R. M. Cinalli, and C. B. Thompson, "Rab7 prevents growth factor-independent survival by inhibiting cellautonomous nutrient transporter expression, " Developmental Cell, vol. 5, no. 4, pp. 571-582, 2003.
50. R. A. Schwartz, G. Fernandez, K. Kotulska, and S. Jozwiak, "Tuberous sclerosis complex: advances in diagnosis, genetics, and management, " Journal of the American Academy of Dermatology, vol. 57, no. 2, pp. 189-202, 2007.
51. A. M. K. Choi, S. W. Ryter, and B. Levine, "Mechanisms of disease: autophagy in human health and disease, "TheNew England Journal of Medicine, vol. 368, no. 7, pp. 651-662, 2013.
52. V. M. Aita, X. H. Liang, V. V. V. S. Murty, et al., "Cloning and genomic organization of beclin 1, a cand idate tumor suppressor gene on chromosome 17q21, " Genomics, vol. 59, no. 1, pp. 5965, 1999.
53. X. Qu, J. Yu, G. Bhagat, et al., "Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene, " Journal of Clinical Investigation, vol. 112, no. 12, pp. 1809-1820, 2003.
54. Z. Yue, S. Jin, C. Yang, A. J. Levine, and N. Heintz, "Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 15077-15082, 2003.
55. Y. Huang, L. Chen, L. Guo, T. R. Hupp, and Y. Lin, "Evaluating DAPK as a therapeutic target, " Apoptosis, vol. 19, no. 2, pp. 371-386, 2014.
56. K. H. Khan, M. Blanco-Codesido, and L. R. Molife, "Cancer therapeutics: targeting the apoptotic pathway, " Critical Reviews in Oncology/Hematology, vol. 90, no. 3, pp. 200-219, 2014.
57. L. Galluzzi, O. Kepp, and G. Kroemer, "Mitochondria: master regulators of danger signalling, " Nature Reviews Molecular Cell Biology, vol. 13, no. 12, pp. 780-788, 2012.
58. S. Pattingre, A. Tassa, X. Qu, et al., "Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy, " Cell, vol. 122, no. 6, pp. 927-939, 2005.
59. M. C. Maiuri, G. le Toumelin, A. Criollo, et al., "Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1, " EMBO Journal, vol. 26, no. 10, pp. 2527-2539, 2007.
60. E. Morselli, L. Galluzzi, O. Kepp, et al., "Anti-and pro-tumor functions of autophagy, " Biochimicaet Biophysica Acta:Molecular Cell Research, vol. 1793, no. 9, pp. 1524-1532, 2009.
61. C. Miracco, E. Cosci, G. Oliveri, et al., "Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours, " International Journal of Oncology, vol. 30, no. 2, pp. 429-436, 2007.
62. V. Karantza-Wadsworth, S. Patel, O. Kravchuk, et al., "Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis, " Genes & Development, vol. 21, no. 13, pp. 1621-1635, 2007.
63. Y. Wei, Z. Zou, N. Becker, et al., "EGFR-mediated beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance, " Cell, vol. 154, no. 6, pp. 1269-1284, 2013.
64. G. Maria Fimia, A. Stoykova, A. Romagnoli, et al., "Ambra1 regulates autophagy and development of the nervous system, " Nature, vol. 447, no. 7148, pp. 1121-1125, 2007.
65. C. Liang, P. Feng, B. Ku, et al., "Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG, " Nature Cell Biology, vol. 8, no. 7, pp. 688-698, 2006.
66. E. White, "Deconvoluting the context-dependent role for autophagy in cancer, " Nature Reviews Cancer, vol. 12, no. 6, pp. 401-410, 2012.
67. J. Liu, H. Xia, M. Kimet al., "Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13, " Cell, vol. 147, no. 1, pp. 223-234, 2011.
68. A. Kuma, M. Hatano, M. Matsui, et al., "The role of autophagy during the early neonatal starvation period, " Nature, vol. 432, no. 7020, pp. 1032-1036, 2004.
69. M. Komatsu, S. Waguri, T. Ueno, et al., "Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice, " Journal of Cell Biology, vol. 169, no. 3, pp. 425-434, 2005.
70. T. Saitoh, N. Fujita, M. H. Jang, et al., "Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production, " Nature, vol. 456, no. 7219, pp. 264-268, 2008.
71. T. Saitoh, F. Naonobu, T. Yoshimori, and S. Akira, "Regulationof inflammation by autophagy, " Tanpakushitsu kakusan koso, vol. 54, supplement 8, pp. 1119-1124, 2009.
72. Y.-S. Sou, S. Waguri, J.-I. Iwata, et al., "The Atg8 conjugation system is indispensable for proper development of autophagic isolationmembranes in mice, "Molecular Biology of the Cell, vol. 19, no. 11, pp. 4762-4775, 2008.
73. A. Takamura, M. Komatsu, T. Hara, et al., "Autophagy-deficient mice develop multiple liver tumors, " Genes and Development, vol. 25, no. 8, pp. 795-800, 2011.
74. A. M. Strohecker, J. Y. Guo, G. Karsli-Uzunbas, et al., "Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors, " Cancer Discovery, vol. 3, no. 11, pp. 1272-1285, 2013.
75. V. I. Kashuba, R. Z. Gizatullin, A. I. Protopopov, et al., "NotI linking/ jumping clones of human chromosome 3: mapping of the TFRC, RAB7 and HAUSP genes to regions rearranged in leukemia and deleted in solid tumors, " FEBS Letters, vol. 419, no. 2-3, pp. 181185, 1997.
76. S. V. Laddha, S. Ganesan, C. S. Chan, and E. White, "Mutational land scape of the essential autophagy gene BECN1 in human cancers, "Molecular Cancer Research, vol. 12, no. 4, pp. 485-490, 2014.
77. L. J. Marnett, "Oxyradicals and DNA damage, " Carcinogenesis, vol. 21, no. 3, pp. 361-370, 2000.
78. M. E. Goetz and A. Luch, "Reactive species: a cell damaging rout assisting to chemical carcinogens, " Cancer Letters, vol. 266, no. 1, pp. 73-83, 2008.
79. L. Galluzzi, E. Morselli, O. Kepp, et al., "Mitochondrial gateways to cancer, "Molecular Aspects of Medicine, vol. 31, no. 1, pp. 1-20, 2010.
80. R. Mathew, S. Kongara, B. Beaudoin, et al., "Autophagy suppresses tumor progression by limiting chromosomal instability, " Genes and Development, vol. 21, no. 11, pp. 1367-1381, 2007.
81. R. Mathew, C. M. Karp, B. Beaudoin, et al., "Autophagy suppresses tumorigenesis through elimination of p62, " Cell, vol. 137, no. 6, pp. 1062-1075, 2009.
82. E. Morselli, L. Galluzzi, O. Kepp, et al., "Oncosuppressive functions of autophagy, " Antioxidants and Redox Signaling, vol. 14, no. 11, pp. 2251-2269, 2011.
83. J. Y. Guo, H.-Y. Chen, R. Mathew, et al., "Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis, " Genes and Development, vol. 25, no. 5, pp. 460-470, 2011.
84. J. Y. Guo, G. Karsli-Uzunbas, R. Mathew, et al., "Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis, " Genes and Development, vol. 27, no. 13, pp. 1447-1461, 2013.
85. S. H. Yang, X. Wang, G. Contino, et al., "Pancreatic cancers require autophagy for tumor growth, " Genes and Development, vol. 25, no. 7, pp. 717-729, 2011.
86. S. Geisler, K. M. Holmstrom, D. Skujat, et al., "PINK1/Parkinmediated mitophagy is dependent on VDAC1 and p62/SQSTM1, " Nature Cell Biology, vol. 12, no. 2, pp. 119-131, 2010.
87. J. Moscat and M. T. Diaz-Meco, "p62 at the crossroads of autophagy, apoptosis, and cancer, " Cell, vol. 137, no. 6, pp. 1001-1004, 2009.
88. Y. Inami, S. Waguri, A. Sakamoto, et al., "Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells, " Journal of Cell Biology, vol. 193, no. 2, pp. 275-284, 2011.
89. M. Komatsu, H. Kurokawa, S. Waguri, et al., "The selective autophagy substrate p62 activates the stress responsive transcription factorNrf2 through inactivation of Keap1, " Nature Cell Biology, vol. 12, no. 3, pp. 213-223, 2010.
90. A. Lau, X.-J. Wang, F. Zhao, et al., "A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between keap1 and p62, "Molecular and Cellular Biology, vol. 30, no. 13, pp. 3275-3285, 2010.
91. J. Cand ido and T. Hagemann, "Cancer-related inflammation, " Journal of Clinical Immunology, vol. 33, supplement 1, pp. S79-S84, 2013.
92. K. Degenhardt, R. Mathew, B. Beaudoin, et al., "Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis, " Cancer Cell, vol. 10, no. 1, pp. 51-64, 2006.
93. E. White and R. S. DiPaola, "The double-edged sword of autophagy modulation in cancer, " Clinical Cancer Research, vol. 15, no. 17, pp. 5308-5316, 2009.
94. X. Qu, Z. Zou, Q. Sun, et al., "Autophagy gene-dependent clearance of apoptotic cells during embryonic development, " Cell, vol. 128, no. 5, pp. 931-946, 2007.
95. B. Levine, N. Mizushima, and H. W. Virgin, "Autophagy in immunity and inflammation, " Nature, vol. 469, no. 7330, pp. 323-335, 2011.
96. G. Kroemer and B. Levine, "Autophagic cell death: the story of a misnomer, " Nature Reviews Molecular Cell Biology, vol. 9, no. 12, pp. 1004-1010, 2008.
97. M. Elgendy, C. Sheridan, G. Brumatti, and S. J. Martin, "Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival, "Molecular Cell, vol. 42, no. 1, pp. 23-35, 2011.
98. Y. Zhao, J. Yang, W. Liao, et al., "Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity, " Nature Cell Biology, vol. 12, no. 7, pp. 665-675, 2010.
99. Y. Zhao, L. Wang, J. Yang, et al., "Anti-neoplastic activity of the cytosolic FoxO1 results from autophagic cell death, " Autophagy, vol. 6, no. 7, pp. 988-990, 2010.
100. A. R. J. Young, M. Narita, M. Ferreira, et al., "Autophagy mediates themitotic senescence transition, " Genes and Development, vol. 23, no. 7, pp. 798-803, 2009.
101. A. C. Kimmelman, "The dynamic nature of autophagy in cancer, " Genes and Development, vol. 25, no. 19, pp. 1999-2010, 2011.
102. R. W. Goehe, X. Di, K. Sharma, et al., "The autophagy-senescence connection in chemotherapy: must tumor cells (self) eat before they sleep, " Journal of Pharmacology and ExperimentalTherapeutics, vol. 343, no. 3, pp. 763-778, 2012.
103. D. A. Gewirtz, "Autophagy and senescence in cancer therapy., " Journal of cellular physiology, vol. 229, no. 1, pp. 6-9, 2014.
104. A. E. Karnoub and R. A. Weinberg, "Ras oncogenes: split personalities, " Nature ReviewsMolecular Cell Biology, vol. 9, no. 7, pp. 517-531, 2008.
105. A. Jemal, R. Siegel, J. Xu, and E. Ward, "Cancer statistics, 2010, " CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277-300, 2010.
106. S. Fujii, S. Mitsunaga, M. Yamazaki, et al., "Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome, " Cancer Science, vol. 99, no. 9, pp. 1813-1819, 2008.
107. A. Yang, N. V. Rajeshkumar, X. Wang, et al., "Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations, " Cancer Discovery, vol. 4, no. 8, pp. 905-913, 2014.
108. M. T. Rosenfeldt, J. O'Prey, J. P. Morton, et al., "P53 status determines the role of autophagy in pancreatic tumour development, " Nature, vol. 504, no. 7479, pp. 296-300, 2013.
109. R. Lock, S. Roy, C. M. Kenific, et al., "Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation, " Molecular Biology of the Cell, vol. 22, no. 2, pp. 165-178, 2011.
110. S. Y. Chun, C. Johnson, J. G. Washburn, M. R. Cruz-Correa, D. T. Dang, and L. H. Dang, "Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes, " Molecular Cancer, vol. 9, article 293, 2010.
111. B. Zheng, J. H. Jeong, J. M. Asara, et al., "Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation, " Molecular Cell, vol. 33, no. 2, pp. 237-247, 2009.
112. W. Kalas, E. Swiderek, A. Rapak, M. Kopij, J. Rak, and L. Strzadala, "H-ras Up-regulates expression of BNIP3, " Anticancer Research, vol. 31, no. 9, pp. 2869-2875, 2011.
113. S.-Y. Wu, S.-H. Lan, D.-E. Cheng, et al., "Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation, " Neoplasia, vol. 13, no. 12, pp. 1171-1182, 2011.
114. H.-J. An, O. Maeng, K.-H. Kang, et al., "Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death, " Journal of Biological Chemistry, vol. 281, no. 45, pp. 33939-33948, 2006.
115. H. Wei, S. Wei, B. Gan, X. Peng, W. Zou, and J.-L. Guan, "Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis, "Genes and Development, vol. 25, no. 14, pp. 1510-1527, 2011.
116. B. A. Smith, D. N. Shelton, C. Kieffer, et al., "Targeting the PyMT oncogene to diversemammary cell populations enhances tumor heterogeneity and generates rare breast cancer subtypes, " Genes and Cancer, vol. 3, no. 9-10, pp. 550-563, 2012.
117. Y. Huo, H. Cai, I. Teplova, et al., "Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer, " Cancer Discovery, vol. 3, no. 8, pp. 894-907, 2013.
118. R. Mathew and E. White, "Autophagy, stress, and cancer metabolism: what doesnt kill you makes you stronger, " Cold Spring Harbor Symposia on Quantitative Biology, vol. 76, pp. 389-396, 2011.
119. A. F. G. Quest, J. L. Gutierrez-Pajares, and V. A. Torres, "Caveolin-1: an ambiguous partner in cell signalling and cancer, " Journal of Cellular and Molecular Medicine, vol. 12, no. 4, pp. 1130-1150, 2008.
120. A. F. G. Quest, L. Leyton, and M. Parraga, "Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease, " Biochemistry and Cell Biology, vol. 82, no. 1, pp. 129-144, 2004.
121. A. F. G. Quest, L. Lobos-Gonzalez, S. Nunez, et al., "The Caveolin connection to cell death and survival, " CurrentMolecular Medicine, vol. 13, no. 2, pp. 266-281, 2013.
122. L. Lobos-Gonzalez, L. Aguilar, J. Diaz, et al., "E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells, " Pigment Cell and Melanoma Research, vol. 26, no. 4, pp. 555-570, 2013.
123. D. A. Rodriguez, J. C. Tapia, J. G. Fernandez, et al., "Caveolin-1-mediated suppression of cyclooxygenase-2 via a β-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostagLandin E2 production and survivin expression, " Molecular Biology of the Cell, vol. 20, no. 8, pp. 2297-2310, 2009.
124. V. A. Torres, J. C. Tapia, D. A. Rodriguez, et al., "Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin, " Journal of Cell Science, vol. 119, part 9, pp. 1812-1823, 2006.
125. V. A. Torres, J. C. Tapia, D. A. Rodriguez, et al., "E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced β-catenin-Tcf/Lef-dependent transcription, " Molecular and Cellular Biology, vol. 27, no. 21, pp. 7703-7717, 2007.
126. U. E. Martinez-Outschoorn, C. Trimmer, Z. Lin, et al., "Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment, " Cell Cycle, vol. 9, no. 17, pp. 3515-3533, 2010.
127. F. Sotgia, U. E. Martinez-Outschoorn, A. Howell, R. G. Pestell, S. Pavlides, and M. P. Lisanti, "Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms, " Annual Review of Pathology:Mechanisms of Disease, vol. 7, pp. 423-467, 2012.
128. T.-K. Ha, N.-G. Her, M.-G. Lee, et al., "Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription, " Cancer Research, vol. 72, no. 16, pp. 4097-4109, 2012.
129. T. Shiroto, N. Romero, T. Sugiyama, et al., "Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium, " PLoS ONE, vol. 9, no. 2, Article ID e87871, 2014.
130. Z.-H. Chen, J.-F. Cao, J.-S. Zhou, et al., "Interaction of caveolin with ATG12-ATG5 system suppresses autophagy in lung epithelial cells, " The American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 306, no. 11, pp. L1016-L1025, 2014.
131. O. Meynet and J.-E. Ricci, "Caloric restriction and cancer:molecular mechanisms and clinical implications, " Trends in Molecular Medicine, vol. 20, no. 8, pp. 419-427, 2014.
132. M. Malek, R. Aghili, Z. Emami, and M. E. Khamseh, "Risk of cancer in diabetes: the effect of metformin, " ISRN Endocrinology, vol. 2013, Article ID 636927, 9 pages, 2013.